- Patent Title: Protein tyrosine phosphatase inhibitors and methods of use thereof
-
Application No.: US17025644Application Date: 2020-09-18
-
Publication No.: US10954202B2Publication Date: 2021-03-23
- Inventor: Zhaoming Xiong , Jennifer M. Frost , Philip R. Kym , Xueqing Wang , Shuang Chen , Dennie Welch
- Applicant: Calico Life Sciences LLC , AbbVie Inc.
- Applicant Address: US CA South San Francisco; US IL North Chicago
- Assignee: Calico Life Sciences LLC,AbbVie Inc.
- Current Assignee: Calico Life Sciences LLC,AbbVie Inc.
- Current Assignee Address: US CA South San Francisco; US IL North Chicago
- Agency: Goodwin Procter LLP
- Main IPC: C07D285/10
- IPC: C07D285/10
Abstract:
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.
Public/Granted literature
- US20210009542A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF Public/Granted day:2021-01-14
Information query
